
XPEL, Inc.
XPELNASDAQConsumer Cyclical● Active
$45.64
+$1.08(+2.43%)
Market Cap$1.3B
P/E Ratio—
52W High$55.91
52W Low$31.26
XPEL, Inc.(XPEL)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · XPEL · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.48B | $0.42B | $0.40B | $0.32B | $0.26B |
| Cost of Revenue | $0.28B | $0.24B | $0.23B | $0.20B | $0.17B |
| Gross Profit | $0.20B | $0.18B | $0.16B | $0.13B | $0.09B |
| Gross Margin %(computed) | 42.21% | 42.19% | 40.98% | 39.36% | 35.75% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.09B | $0.08B | $0.06B | $0.05B | $0.03B |
| Total Operating Expenses | $0.14B | $0.12B | $0.10B | $0.07B | $0.05B |
| Operating Income | $0.06B | $0.06B | $0.07B | $0.05B | $0.04B |
| Operating Margin %(computed) | 13.16% | 14.07% | 16.90% | 16.65% | 15.47% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.06B | $0.06B | $0.07B | $0.05B | $0.04B |
| Income Tax Expense | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Net Income | $0.05B | $0.05B | $0.05B | $0.04B | $0.03B |
| Net Margin %(computed) | 10.76% | 10.82% | 13.32% | 12.77% | 12.18% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.85 | $1.65 | $1.91 | $1.50 | $1.14 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| EBITDA | $0.08B | $0.07B | $0.08B | $0.06B | $0.04B |
| EBITDA Margin %(computed) | 16.25% | 16.52% | 19.40% | 18.89% | 17.02% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B
深入了解XPEL, Inc.
关于XPEL, Inc.(XPEL)损益表
XPEL, Inc.(XPEL)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,XPEL实现营收$0.48B,毛利润$0.20B(毛利率42.21%),净利润$0.05B(净利率10.76%)。
常见问题
XPEL · 4 问XPEL, Inc.(XPEL)2025财年营收为$0.48B,同比up13.3%。
XPEL revenueXPEL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08